阻塞性睡眠呼吸暂停低通气综合征和代谢综合征关系的研究进展
Research Progress on the Relationship between Obstructive Sleep Apnea Hypopnea Syndrome and Metabolic Syndrome
DOI: 10.12677/ACM.2024.141052, PDF,   
作者: 赵婷婷, 王 宁*, 张 玉：新疆医科大学第一附属医院综合内一科，新疆 乌鲁木齐
关键词: 阻塞性睡眠呼吸暂停低通气综合征；代谢综合征；关系；Obstructive Sleep Apnea Hypopnea Syndrome； Metabolic Syndrome； Relationship
摘要: 阻塞性睡眠呼吸暂停综合征和代谢综合征均可对心血管、内分泌、中枢神经等多系统造成损伤，而最常见、且最严重的损伤发生在心血管系统。阻塞性睡眠呼吸暂停综合征和代谢综合征均可显著增加CVD发病和CVD相关死亡风险。阻塞性睡眠呼吸暂停综合征合并代谢综合征人群发生CVD风险显著高于正常人群，严重降低生活质量，缩短预期寿命。研究阻塞性睡眠呼吸暂停综合征和代谢综合征的关系将有助于降低心血管事件的发生。
Abstract: Both Obstructive Sleep Apnea Hypopnea Syndrome and Metabolic Syndrome can cause damage to cardiovascular, endocrine, central nervous system and other systems, and the most common and serious damage occurs in the cardiovascular system. Both OSAHS and MS significantly increase the risk of CVD morbidity and CVD-related death. The risk of CVD in patients with obstructive sleep ap-nea syndrome combined with metabolic syndrome is significantly higher than that in the normal population, which can seriously reduce the quality of life and shorten the life expectancy. Studying the relationship between obstructive sleep apnea syndrome and metabolic syndrome will contrib-ute to the occurrence of cardiovascular events.
文章引用：赵婷婷, 王宁, 张玉. 阻塞性睡眠呼吸暂停低通气综合征和代谢综合征关系的研究进展[J]. 临床医学进展, 2024, 14(1): 357-362. https://doi.org/10.12677/ACM.2024.141052

参考文献

[1] 阻塞性睡眠呼吸暂停合并代谢综合征诊疗专家共识组. 阻塞性睡眠呼吸暂停合并代谢综合征诊疗专家共识(2022) [J]. 中华耳鼻咽喉头颈外科杂志, 2023, 58(2): 99-110. [Google Scholar] [CrossRef] [PubMed]
[2] Karuga, F.F., Kaczmarski, P., Białasiewicz, P., Szmyd, B., Jaromirska, J., Grzybowski, F., Gebuza, P., Sochal, M. and Gabryelska, A. (2023) REM-OSA as a Tool to Understand both the Architecture of Sleep and Pathogenesis of Sleep Apnea-Literature Review. Journal of Clinical Med-icine, 12, Article 5907. [Google Scholar] [CrossRef] [PubMed]
[3] Kurosawa, H., Saisho, Y., Fukunaga, K., et al. (2018) Association between Severity of Obstructive Sleep Apnea and Glycated Hemoglobin Level in Japanese Individu-als with and without Diabetes. Endocrine Journal, 65, 121-127. [Google Scholar] [CrossRef] 
[4] Wang, X., Bi, Y., Zhang, Q. and Pan, F. (2013) Obstructive Sleep Apnoea and the Risk of Type 2 Diabetes: A Meta-Analysis of Prospective Cohort Studies. Respirology, 18, 140-146. [Google Scholar] [CrossRef] [PubMed]
[5] Schmidt, F., Nowak, N., Baumgartner, P., Gaisl, T., Malesevic, S., Streckenbach, B., Sievi, N.A., Schwarz, E.I., Zenobi, R., Brown, S.A. and Kohler, M. (2022) Severe Ob-structive Sleep Apnea Disrupts Vigilance-State-Dependent Metabolism. International Journal of Molecular Sciences, 23, Article 14052. [Google Scholar] [CrossRef] [PubMed]
[6] Lechat, B., Naik, G., Reynolds, A., Aishah, A., Scott, H., Loffler, K.A., Vakulin, A., Escourrou, P., McEvoy, R.D., Adams, R.J., Catcheside, P.G. and Eckert, D.J. (2022) Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine, 205, 563-569. [Google Scholar] [CrossRef] 
[7] Benjafield, A.V., Ayas, N.T., Eastwood, P.R., Heinzer, R., Ip, M.S.M., Morrell, M.J., Nunez, C.M., Patel, S.R., Penzel, T., Pépin, J.L., Peppard, P.E., Sinha, S., Tufik, S., Valentine, K. and Malhotra, A. (2019) Estimation of the Global Prevalence and Burden of Obstructive Sleep Apnoea: A Litera-ture-Based Analysis. The Lancet Respiratory Medicine, 7, 687-698. [Google Scholar] [CrossRef] 
[8] Malhotra, A., Morrell, M.J. and Eastwood, P.R. (2018) Up-date in Respiratory Sleep Disorders: Epilogue to a Modern Review Series. Respirology, 23, 16-17. [Google Scholar] [CrossRef] [PubMed]
[9] Jordan, A.S., McSharry, D.G. and Malhotra, A. (2014) Adult Obstructive Sleep Apnoea. The Lancet, 383, 736-747. [Google Scholar] [CrossRef] 
[10] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) (上) [J]. 中国实用内科杂志, 2021, 41(8): 668-695.
[11] 谭树凤, 王凤, 沈红卫, 等. 上海某郊区老年健康体检人群血尿酸水平与代谢综合征的关系研究[J]. 老年医学与保健, 2021, 27(3): 606-608, 617.
[12] 朱良栋, 刘洪林, 赵丹, 等. 阻塞型睡眠呼吸暂停低通气综合征与代谢综合征相关性的研究进展[J]. 华西医学, 2022, 37(1): 116-119.
[13] 中华医学会呼吸病学分会睡眠学组, 中华医学会糖尿病学分会. 阻塞性睡眠呼吸暂停与糖尿病专家共识[J]. 中华结核和呼吸杂志, 2010, 33(5): 326-330.
[14] 刘跃男, 许华俊, 钱颖君, 等. 阻塞性睡眠呼吸暂停低通气综合征和代谢综合征关系的最新研究进展[J]. 中国眼耳鼻喉科杂志, 2021, 21(4): 305-308. [Google Scholar] [CrossRef] 
[15] Siopi, D. and Steiropoulos, P. (2023) The Influence of CPAP Therapy on Basal Metabolic Rate and Physical Activity in Obese Patients with Obstructive Sleep Apnea. Nutrients, 15, Article 4446. [Google Scholar] [CrossRef] [PubMed]
[16] 罗远明, 贺白婷. 阻塞性睡眠呼吸暂停的发病机制与诊断的热点问题[J]. 中华结核和呼吸杂志, 2015, 38(9): 643-645.
[17] 苏梅, 曹娟, 魏建军, 等. 三水平和双水平正压通气对合并中重度阻塞性睡眠呼吸暂停的肥胖低通气综合征患者疗效的比较[J]. 内科理论与实践, 2019, 14(4): 230-234.
[18] 张思颖, 鲁垚皓, 廖金萍, 等. 阻塞性睡眠呼吸暂停低通气综合征患者自动正压通气治疗压力值的影响因素分析[J]. 中国循环杂志, 2021, 36(1): 53-56.
[19] Pamuk, A.E., Süslü, A.E., Yalgınkaya, A., et al. (2018) The Serum Leptin Level in Non-Obese Patients with Obstructive Sleep Apnea. Auris Nasus Larynx, 45, 796-800. [Google Scholar] [CrossRef] [PubMed]
[20] Ciriello, J., Moreau, J.M., Caverson, M.M. and Moranis, R. (2022) Leptin: A Potential Link between Obstructive Sleep Apnea and Obesity. Frontiers in Physiology, 12, Article 767318. [Google Scholar] [CrossRef] [PubMed]
[21] Muraki, I., Wada, H. and Tanigawa, T. (2018) Sleep Apnea and Type 2 Diabetes. Journal of Diabetes Investigation, 9, 991-997. [Google Scholar] [CrossRef] [PubMed]
[22] Reutrakul, S. and Mokhlesi, B. (2017) Obstructive Sleep Apnea and Diabetes: A State of the Art Review. Chest, 152, 1070-1086. [Google Scholar] [CrossRef] [PubMed]
[23] Ogilvie, R.P. and Patel, S.R. (2018) The Epidemiology of Sleep and Diabetes. Current Diabetes Reports, 18, Article No. 82. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, Y., Xing, Y., Yuan, H., et al. (2018) Impaired Glucose Metabolisms of Patients with Obstructive Sleep Apnea and Type 2 Diabetes. Journal of Diabetes Research, 2018, Article ID: 6714392. [Google Scholar] [CrossRef] [PubMed]
[25] Wen, W., Sun, H., Yang, Y., et al. (2020) Usefulness of Cathepsin S to Predict Risk for Obstructive Sleep Apnea among Patients with Type 2 Diabetes. Disease Markers, 2020, Article ID: 8819134. [Google Scholar] [CrossRef] [PubMed]
[26] Kumar, W., Martins, R.S., Anjum, N. and Fatima, S.S. (2022) Ischemia Modified Albumin as a Useful Marker for Diagnoses and Management of Diabetic Retinopathy. Pakistan Journal of Medical Sciences, 38, 1043-1047. [Google Scholar] [CrossRef] [PubMed]
[27] Yamamoto, Y., Fujiuchi, S., Hiramatsu, M., et al. (2008) Resistin Is Closely Related to Systemic Inflammation in Obstructive Sleep Apnea. Respiration, 76, 377-385. [Google Scholar] [CrossRef] [PubMed]
[28] Arden, G.B. and Sivaprasad, S. (2012) The Pathogenesis of Early Retinal Changes of Diabetic Retinopathy. Documenta Ophthalmologica, 124, 15-26. [Google Scholar] [CrossRef] [PubMed]
[29] Salman, L.A., Shulman, R. and Cohen, J.B. (2020) Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management. Current Car-diology Reports, 22, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[30] Cai, A.P., Wang, L. and Zhou, Y.L. (2016) Hypertension and Obstructive Sleep Apnea. Hypertension Research, 39, 391-395. [Google Scholar] [CrossRef] [PubMed]
[31] 肖永龙. 睡眠呼吸暂停综合征与代谢紊乱关系研究进展[J]. 国外医学•呼吸系统分册, 2000, 20(1): 23-24.
[32] Donovan, L.M., McDowell, J.A., Pannick, A.P., Pai, J., Bais, A.F., Plumley, R., Wai, T.H., Grunwald, G.K., Josey, K., Sayre, G.G., Helfrich, C.D., Zeliadt, S.B., Hoerster, K.D., Ma, J. and Au, D.H. (2023) Protocol for a Pragmatic Trial Testing a Self-Directed Lifestyle Program Targeting Weight Loss among Patients with Obstructive Sleep Apnea (POWER Trial). Contemporary Clinical Trials, 135, Article ID: 107378. [Google Scholar] [CrossRef] [PubMed]

为你推荐